Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Insights into how the body clock and time of day influence immune responses have been revealed in a study published in the journal...

New international research finds that people living with multiple sclerosis (MS) prioritise slowing disease progression when considering treatment choices. People with MS want therapies that...

Two researchers in the department of anatomy and cell biology in the University of Illinois at Chicago (UIC) College of Medicine have received a seed grant to develop a new drug delivery method...

Active Biotech drug, laquinimod has failed a phase II trial in primary progressive MS.

Laquinimod a once-daily oral drug targets neurodegeneration and inflammation with a novel mechanism of...

Early medical intervention for the treatment of multiple sclerosis (MS) has been debated by experts for a number of years, with the likes of Gavin Giovannoni a Professor at Barts and the London...

A recent study has associated brain inflammation with depression and anxiety in patients with relapsing remitting multiple sclerosis (RRMS).

The study,...

Different types of immune cells gain access to nerve cells in the brain and spinal cord in different ways, according to multiple sclerosis (MS) researchers based at the University of Illinois in...

MMJ BioScience has hired Dr Bianca Weinstock-Guttman as the principle investigator to lead its patient clinical research into medical marijuana.

Dr Bianca Weinstock-Guttman is a Professor...

Scientists who conducted research into how physical activity impacts depression and sleep in people with MS found a positive effect on their physiological function and sleep.

There is...

Roche, the makers of ocrelizumab have today announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for the use of ocrelizumab in adults with active...

Pages

Live Chat Software by Click4Assistance UK